Financing, Equity Capital Markets

Infinity Pharmaceuticals, Inc.

02/21
|
$91.7 Million
Piper Sandler served as sole bookrunner for Infinity Pharmaceuticals, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma